TOMM34 expression in early invasive breast cancer: a biomarker associated with poor outcome. (Q50489396)

14 March 2018

title

TOMM34 expression in early invasive breast cancer: a biomarker associated with poor outcome. (English)

1 reference

14 March 2018

1 reference

Ola H Negm

2

0 references

Mohammed A Aleskandarany

Mohammed A Aleskandarany

1

0 references

Patrick J Tighe

Patrick J Tighe

9

0 references

Andrew Green

Andrew R Green

8

0 references

Emad A. Rakha

Emad A Rakha

3

0 references

Ian Ellis

Ian O Ellis

10

0 references

Carlos Caldas

7

Carlos Caldas

1 reference

14 March 2018

Mohamed A H Ahmed

4

1 reference

14 March 2018

Christopher C Nolan

5

1 reference

14 March 2018

Graham R Ball

6

1 reference

14 March 2018

language of work or name

English

0 references

publication date

4 October 2012

1 reference

14 March 2018

Breast Cancer Research and Treatment

published in

1 reference

14 March 2018

volume

136

1 reference

14 March 2018

page(s)

419-427

1 reference

14 March 2018

issue

2

1 reference

14 March 2018

https://scigraph.springernature.com/pub.10.1007/s10549-012-2249-4

exact match

0 references

cites work

Current and emerging biomarkers in breast cancer: prognosis and prediction

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2249-4

Mitochondria: more than just a powerhouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2249-4

Mitochondrial free radical production and cell signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2249-4

Mitochondrial defects in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2249-4

Mitochondrial protein import and human health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2249-4

hTom34: a novel translocase for the import of proteins into human mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2249-4

Characterization of the novel mitochondrial protein import component, Tom34, in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2249-4

REporting recommendations for tumor MARKer prognostic studies (REMARK).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2249-4

High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2249-4

Triple-negative breast cancer: distinguishing between basal and nonbasal subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2249-4

A gene-expression signature to predict survival in breast cancer across independent data sets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2249-4

The proteins FABP7 and OATP2 are associated with the basal phenotype and patient outcome in human breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2249-4

Development and validation of a novel protein extraction methodology for quantitation of protein expression in formalin-fixed paraffin-embedded tissues using western blotting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2249-4

Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2249-4

The effects of fixation, processing and evaluation criteria on immunohistochemical detection of hormone receptors in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2249-4

10.1007/S10549-012-2249-4

21 January 2018

Identifiers

DOI

1 reference

14 March 2018

PubMed ID

23053644

1 reference

14 March 2018